736 Can pharmacogenetics predict chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with taxane-based chemotherapy?

Abstract

Introduction/Background*Taxane-based chemotherapy used in treating gynecologic malignancies, results in one third of patients developing grade 2 or higher chemotherapy induced peripheral neuropathy (CIPN). Currently, there is no test which predicts...